The Impact of Suppressing Estradiol During Ovarian Stimulation on the Unsupported Luteal Phase: A Randomized Controlled Trial
Research output: Contribution to journal › Journal article › Research › peer-review
Context Supraphysiological sex steroid levels at the follicular-luteal phase transition are implicated as the primary cause of luteal insufficiency after ovarian stimulation (OS) for in vitro fertilization. Objective We aimed to determine the impact of suppressing estradiol levels during OS of multiple dominant follicles on the unsupported luteal phase and markers of endometrial maturation. Methods At 2 university hospitals, 25 eligible egg donors were randomized to undergo OS using exogenous gonadotropins with or without adjuvant letrozole 5 mg/day. Final oocyte maturation was triggered with a GnRH agonist. No luteal support was provided. The primary outcome was the duration of the luteal phase. Secondary outcomes were luteal phase hormone profiles and the endometrial transcriptomic signature 5 days after oocyte pick up (OPU + 5). Results The median (interquartile range [IQR]) luteal phase duration was 8.0 (6.8-11.5) days compared with 5.0 (5.0-6.8) days in the intervention and control group, respectively (P < 0.001). Estradiol levels were effectively suppressed in the letrozole group with a median of 0.86 (0.23-1.24) nmol/L at OPU compared to 2.82 (1.34-3.44) nmol/L in the control group. Median (IQR) progesterone levels at OPU + 5 were 67.05 (15.67-101.75) nmol/L in the letrozole group vs 2.27 (1.05-10.70) nmol/L in the control group (P < 0.001). In the letrozole group, 75% of participants revealed endometrial transcriptomic signatures interpreted as post-receptive. In the control group, 40% were post-receptive and 50% noninformative. Conclusion Suppressing estradiol levels in the follicular phase with adjuvant letrozole significantly reduces the disruption of the unsupported luteal phase after OS.
Original language | English |
---|---|
Journal | Journal of Clinical Endocrinology & Metabolism |
Volume | 107 |
Issue number | 9 |
Pages (from-to) | E3633-E3643 |
Number of pages | 11 |
ISSN | 0021-972X |
DOIs | |
Publication status | Published - 2022 |
- letrozole, ovarian stimulation, luteal phase, progesterone, estradiol, in vitro fertilization, HUMAN CHORIONIC-GONADOTROPIN, LETROZOLE CO-TREATMENT, GNRH AGONIST TRIGGER, LUTEINIZING-HORMONE, RESPONDER PATIENTS, OOCYTE MATURATION, PROGESTERONE, IVF, MULTICENTER, GUIDELINES
Research areas
ID: 325378677